Cyclic Cidofovir

Cyclic Cidofovir

SCHEMBL2380283

Nc1ccn(CC2COP(=O)(O)CO2)c(=O)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 1.00
HPRT1 P00492 2/20 0.48
LMNA P02545 3/20 0.36
PDE3A Q14432 3/20 0.36
CACNA1F O60840 2/20 0.36
ALB P02768 2/20 0.36
MAPT P10636 2/20 0.36
CACNA1D Q01668 2/20 0.36
CACNA1S Q13698 2/20 0.36
CACNA1C Q13936 2/20 0.36
POLB P06746 1/20 0.35
THRB P10828 1/20 0.34
MTOR P42345 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
SLC22A6 Q4U2R8 1/20 0.34
POLG P54098 2/20 0.33
PDE4D Q08499 1/20 0.33
SLC29A1 Q99808 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclic Cidofovir SCHEMBL14461986 1.00 FGFR1 (1.00) FGFR1HPRT1LMNAPDE3ACACNA1F
Cyclic Cidofovir SCHEMBL140858 1.00 FGFR1 (1.00) FGFR1HPRT1LMNAPDE3ACACNA1F
SCHEMBL13825656 0.86 FGFR1 (0.75) FGFR1HPRT1LMNAPDE3ACACNA1F
SCHEMBL10047653 0.85 FGFR1 (0.74) FGFR1HPRT1LMNAPDE3ACACNA1F
SCHEMBL13799135 0.85 FGFR1 (0.74) FGFR1HPRT1
SCHEMBL13799138 0.85 FGFR1 (0.74) FGFR1HPRT1
SCHEMBL27292735 0.83 FGFR1 (0.69) FGFR1LMNAPDE3ACACNA1FALB
SCHEMBL14308878 0.82 FGFR1 (0.71) FGFR1HPRT1LMNAPDE3ACACNA1F
SCHEMBL13819331 0.82 FGFR1 (0.70) FGFR1HPRT1LMNAPDE3ACACNA1F
SCHEMBL10047660 0.82 FGFR1 (0.69) FGFR1HPRT1LMNAPDE3ACACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023214017-A1 CYCLIC CIDOFOVIR OR A PRODRUG THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF AFRICAN SWINE FEVER VIROVET NV (BE) 2023-11-09 WO disclosed
US-8017135-B1 Lipid-drug conjugates for local therapy of eye diseases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-09-13 US disclosed
EP-0874858-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1998-11-04 EP disclosed
US-5756486-A CYCLIZED NUCLEOTIDE; VIRICIDE GILEAD SCIENCES, INC. (US) 1998-05-26 US disclosed
US-5717095-A PHOSPHONATES CYTOSINE COMPOUND GILEAD SCIENCES, INC. (US) 1998-02-10 US disclosed
WO-1997024361-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1997-07-10 WO disclosed
US-5591851-A ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 1997-01-07 US disclosed
EP-0719274-A1 METHOD FOR DOSING THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 1996-07-03 EP disclosed
WO-1995007919-A1 METHOD FOR DOSING THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. (US) 1995-03-23 WO disclosed